vimarsana.com

Latest Breaking News On - ஜியோஃப் நஷ் சிமோன் ஹிக்ஸ் - Page 1 : vimarsana.com

Investegate |Cambridge Cognition Announcements | Cambridge Cognition: Interim Results

Investegate |Cambridge Cognition Announcements | Cambridge Cognition: Interim Results
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Investegate |Cambridge Cognition Announcements | Cambridge Cognition: Brain Health Registry Cognitive Assessment Partner

Investegate |Cambridge Cognition Announcements | Cambridge Cognition: Result of AGM and Board Changes

A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;

Bioventix Plc - Result of AGM

Bioventix Plc - Result of AGM PR Newswire Result of AGM Bioventix plc (AIM: BVXP) announces that at its Annual General Meeting ( AGM ), all resolutions put to shareholders were duly passed. For further information please contact: Bioventix plc About Bioventix plc: Bioventix (www.bioventix.com) specialises in the development and commercial supply of high-affinity monoclonal antibodies with a primary focus on their application in clinical diagnostics, such as in automated immunoassays used in blood testing. The antibodies created at Bioventix are generated in sheep and are of particular benefit where the target is present at low concentration and where conventional monoclonal or polyclonal antibodies have failed to produce a suitable reagent. Bioventix currently offers a portfolio of antibodies to customers for both commercial use and R&D purposes, for the diagnosis or monitoring of a broad range of conditions, including heart disease, cancer, fertility, thyroid function and dru

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.